Quarterly report · Q2
2927.TEDINET S100QLNK
Period2022-09-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.4bn | 2022-09-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥23.0bn | 2021-09-01 → 2022-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.2bn | 2021-09-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | ¥678m | 2022-09-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥453m | 2021-09-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | ¥708m | 2022-09-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-09-01 → 2022-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥643m | 2021-09-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥616m | 2022-09-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥560m | 2021-09-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥414m | 2022-09-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥735m | 2021-09-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥307m | 2021-09-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥417m | 2022-09-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥307m | 2021-09-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥39.0bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥37.3bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥35.9bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥26.3bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥24.9bn | at 2022-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥12.6bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥12.4bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.9bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.4bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.8bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.6bn | at 2022-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2021-08-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥397m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥314m | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥791m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.2bn | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥924m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.2bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥774m | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥29.46 | 2022-09-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.01 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.33 | 2021-09-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.84 | 2021-09-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.8 | 2021-12-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥29.45 | 2022-09-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥52.08 | 2021-09-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥21.71 | 2021-09-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 32.3% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.2% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-09-01 → 2023-02-28 | ¥540m |
| Otherother segments | revenue external | 2022-09-01 → 2023-02-28 | ¥540m |
| Otherother segments | segment profit | 2022-09-01 → 2023-02-28 | −¥2m |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥13m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥698m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥698m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | segment profit | 2022-09-01 → 2023-02-28 | −¥121m |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥7.3bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥7.3bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥940m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥103m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-09-01 → 2023-02-28 | ¥12.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-09-01 → 2023-02-28 | ¥12.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-09-01 → 2023-02-28 | ¥933m |
| Otherother segments | revenue | 2021-09-01 → 2022-02-28 | ¥23m |
| Otherother segments | revenue external | 2021-09-01 → 2022-02-28 | ¥23m |
| Otherother segments | segment profit | 2021-09-01 → 2022-02-28 | −¥10m |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥2.3bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥2.3bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | segment profit | 2021-09-01 → 2022-02-28 | −¥122m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥441m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥441m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | segment profit | 2021-09-01 → 2022-02-28 | −¥190m |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥7.6bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥7.6bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | segment profit | 2021-09-01 → 2022-02-28 | ¥992m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥871m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥871m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | segment profit | 2021-09-01 → 2022-02-28 | ¥85m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-09-01 → 2022-02-28 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-09-01 → 2022-02-28 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-09-01 → 2022-02-28 | ¥755m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 536
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -193729000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -12494000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | 202070000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | -24827000 | JPY |
| Other net ope cf | Prior1YTDDuration | -240709000 | JPY |
| Other net ope cf | CurrentYTDDuration | -290496000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 778988000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 446612000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 7179000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 7902000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -31836000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -28271000 | JPY |
| Proceeds from subsidy income2 ope cf | Prior1YTDDuration | 172420000 | JPY |
| Proceeds from subsidy income2 ope cf | CurrentYTDDuration | 35101000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -613166000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -63988000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 313585000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 397356000 | JPY |
| Purchase of property plant and equipment and intangible assets inv cf | Prior1YTDDuration | -546320000 | JPY |
| Purchase of property plant and equipment and intangible assets inv cf | CurrentYTDDuration | -725141000 | JPY |
| Proceeds from sales of property plant and equipment and intangible assets inv cf | Prior1YTDDuration | 334000 | JPY |
| Proceeds from sales of property plant and equipment and intangible assets inv cf | CurrentYTDDuration | 269000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -155376000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -262357000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 134798000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 281773000 | JPY |
| Payments for lease and guarantee deposits inv cf | Prior1YTDDuration | -906684000 | JPY |
| Payments for lease and guarantee deposits inv cf | CurrentYTDDuration | -8682000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | Prior1YTDDuration | 279756000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | CurrentYTDDuration | 44731000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | － | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | -114146000 | JPY |
| Other net inv cf | Prior1YTDDuration | -8249000 | JPY |
| Other net inv cf | CurrentYTDDuration | -7578000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -1201740000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -791130000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | 2000000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 1178242000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | 250000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 72510000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -949998000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -91028000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -288891000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | － | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -212300000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -209886000 | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | Prior1YTDDuration | － | JPY |
| Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation fin cf | CurrentYTDDuration | -601000 | JPY |
| Other net fin cf | Prior1YTDDuration | -25067000 | JPY |
| Other net fin cf | CurrentYTDDuration | -25579000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |